Arcturus Therapeutics Holdings (ARCT) Receivables: 2018-2025
Historic Receivables for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $15.9 million.
- Arcturus Therapeutics Holdings' Receivables fell 73.67% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.4 million, marking a year-over-year decrease of 61.46%. This contributed to the annual value of $7.9 million for FY2024, which is 87.61% down from last year.
- Arcturus Therapeutics Holdings' Receivables amounted to $15.9 million in Q3 2025, which was down 53.78% from $34.4 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Receivables registered a high of $185.0 million during Q1 2023, and its lowest value of $4.0 million during Q1 2021.
- Over the past 3 years, Arcturus Therapeutics Holdings' median Receivables value was $48.2 million (recorded in 2024), while the average stood at $52.8 million.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Receivables spiked by 2,405.64% in 2023 and then tumbled by 87.61% in 2024.
- Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Receivables stood at $6.7 million in 2021, then decreased by 17.91% to $5.5 million in 2022, then surged by 1,060.06% to $64.1 million in 2023, then tumbled by 87.61% to $7.9 million in 2024, then crashed by 73.67% to $15.9 million in 2025.
- Its Receivables was $15.9 million in Q3 2025, compared to $34.4 million in Q2 2025 and $29.1 million in Q1 2025.